📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting KIR as a novel approach to improve CAR-NK cell function. (2023)

First Author: Graham LV

Attributed to: Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.20517/jtgg.2023.25

PubMed Identifier: 38229912

Publication URI: http://europepmc.org/abstract/MED/38229912

Type: Journal Article/Review

Volume: 7

Parent Publication: Journal of translational genetics and genomics

ISSN: 2578-5281